Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Pontarini

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Nature Communications|March 17, 2024
Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritisAlessandra Nerviani, Marie-Astrid Boutet, Giulia Maria Ghirardi, et al.
Communications Biology|May 4, 2022
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interactionSaba Nayar, Elena Pontarini, Joana Campos, et al.
Rheumatology (Oxford, England)|November 22, 2020
Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndromePilar Jimenez-Royo, Michele Bombardieri, Coziana Ciurtin, et al.
Annals of the Rheumatic Diseases|December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's diseaseBaptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Annals of the Rheumatic Diseases|March 19, 2013
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre studyLuca Quartuccio, Martina Fabris, Elena Pontarini, et al.
The Lancet. Rheumatology|October 2, 2025
Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort studyJulien Duquesne, Louis Basseto, Charlotte Claye, et al.
Arthritis and Rheumatism|September 25, 2012
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockersMartina Fabris, Luca Quartuccio, Ed Vital, et al.
Annals of the Rheumatic Diseases|September 23, 2020
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphomaElena Pontarini, William James Murray-Brown, Cristina Croia, et al.
Circulation|November 23, 2022
Circulating c-Met-Expressing Memory T Cells Define Cardiac AutoimmunitySilvia Fanti, Edward Stephenson, Etel Rocha-Vieira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2023
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)Elena Pontarini, Elisabetta Sciacca, Farzana Chowdhury, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Nature Communications|March 17, 2024
Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritisAlessandra Nerviani, Marie-Astrid Boutet, Giulia Maria Ghirardi, et al.
Communications Biology|May 4, 2022
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interactionSaba Nayar, Elena Pontarini, Joana Campos, et al.
Rheumatology (Oxford, England)|November 22, 2020
Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndromePilar Jimenez-Royo, Michele Bombardieri, Coziana Ciurtin, et al.
Annals of the Rheumatic Diseases|December 25, 2025
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's diseaseBaptiste Chevet, Valérie Devauchelle-Pensec, Elena Pontarini, et al.
Annals of the Rheumatic Diseases|March 19, 2013
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre studyLuca Quartuccio, Martina Fabris, Elena Pontarini, et al.
The Lancet. Rheumatology|October 2, 2025
Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort studyJulien Duquesne, Louis Basseto, Charlotte Claye, et al.
Arthritis and Rheumatism|September 25, 2012
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockersMartina Fabris, Luca Quartuccio, Ed Vital, et al.
Annals of the Rheumatic Diseases|September 23, 2020
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphomaElena Pontarini, William James Murray-Brown, Cristina Croia, et al.
Circulation|November 23, 2022
Circulating c-Met-Expressing Memory T Cells Define Cardiac AutoimmunitySilvia Fanti, Edward Stephenson, Etel Rocha-Vieira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 10, 2023
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)Elena Pontarini, Elisabetta Sciacca, Farzana Chowdhury, et al.
Pageof 6